Loratadine isn’t known to interact with alcohol. But alcohol and loratadine can cause some of the same side effects, such as headache and fatigue (low energy).

Loratadine and fexofenadine are newer anti-histamines that are rapidly absorbed following oral administration; these agents do not readily penetrate the blood-brain barrier and are not associated ...

Loratadine and fexofenadine were superior to placebo in reducing the symptoms of SAR. Compared with fexofenadine, loratadine provided significantly greater relief in symptoms of SAR at four of the ...

Research Highlight Published: 01 April 2006 Loratadine disrupts penile development in mice Tamsin Osborne Nature Clinical Practice Urology 3, 178–179 (2006) Cite this article ...

The common antihistamine loratadine—the active ingredient in over-the-counter medications such as Claritin, Alerclear, and Alavert—makes some species of antibiotic-resistant bacteria ...

Alerta 10mg - 10 Tablets (Loratadine) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is manufactured by Gary ...

Loratadine (Lormeg (30 ml)) is an antihistamine, prescribed for allergic conditions.It blocks histamine action, which reduces allergy symptoms. The information provided on this page is intended to ...

"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd, for Loratadine tablets USP, 10 mg (OTC)," Granules India said in a ...

Loratadine, an antihistamine found in over-the-counter allergy medicines, may be able to help kill the bacteria associated with Lyme disease (Borrelia burgdorferi).

India Business News: MUMBAI: Ranbaxy has got the US FDA's approval to market Loratadine, the generic version of Schering-Plough Corp's anti-allergy Claritin tablets.

Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet KENILWORTH and WHITEHOUSE STATION, N.J., Aug. 28 -- ...

Morepen Laboratories Limited has received approval from the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) for its anti-allergy API, Loratadine.